Illumina is a diagnostics & research business based in the US. Illumina stocks (ILMN.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $239.81 – an increase of 2.68% over the previous week. Illumina employs 9,800 staff and has a trailing 12-month revenue of around $4.5 billion.
How to buy stocks in Illumina
- Compare stock trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – ILMN – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of stocks with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in Illumina?
- Has coronavirus impacted Illumina shares?
- Illumina shares summary
- Compare share dealing platforms
- Is Illumina stock a buy or sell?
- Illumina performance over time
- Is Illumina suitable for ethical investing?
- Are Illumina shares over-valued?
- Illumina's financials
- How volatile are Illumina shares?
- Does Illumina pay a dividend?
- Have Illumina shares ever split?
- Other common questions
Illumina stock price (NASDAQ:ILMN)Use our graph to track the performance of ILMN stocks over time.
Illumina shares at a glance
|Latest market close||$239.81|
|52-week range||$208.35 - $526.00|
|50-day moving average||$319.33|
|200-day moving average||$382.21|
|Wall St. target price||$371.38|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$5.04|
Compare stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Illumina stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Illumina price performance over time
|1 week (2022-05-10)||9.17%|
|1 month (2022-04-19)||-29.94%|
|3 months (2022-02-18)||-23.13%|
|6 months (2021-11-19)||-36.78%|
|1 year (2021-05-20)||-39.52%|
|2 years (2020-05-20)||-32.96%|
|3 years (2019-05-20)||300.59|
|5 years (2017-05-19)||35.48%|
Is Illumina under- or over-valued?
Valuing Illumina stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Illumina's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Illumina's P/E ratio
Illumina's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 46x. In other words, Illumina shares trade at around 46x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Illumina's PEG ratio
Illumina's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.8598. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Illumina's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Illumina's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $903 million.
The EBITDA is a measure of a Illumina's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$4.5 billion|
|Operating margin TTM||14.41%|
|Gross profit TTM||$3.2 billion|
|Return on assets TTM||3.57%|
|Return on equity TTM||9.87%|
|Market capitalisation||$36.7 billion|
TTM: trailing 12 months
Illumina's environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Illumina.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Illumina's total ESG risk score
Total ESG risk: 9.18
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Illumina's overall score of 9.18 (as at 01/01/2019) is excellent – landing it in it in the 2nd percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Illumina is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Illumina's environmental score
Environmental score: 2.22/100
Illumina's environmental score of 2.22 puts it squarely in the 2nd percentile of companies rated in the same sector. This could suggest that Illumina is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Illumina's social score
Social score: 2.6/100
Illumina's social score of 2.6 puts it squarely in the 2nd percentile of companies rated in the same sector. This could suggest that Illumina is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Illumina's governance score
Governance score: 5.36/100
Illumina's governance score puts it squarely in the 2nd percentile of companies rated in the same sector. That could suggest that Illumina is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Illumina's controversy score
Controversy score: 1/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Illumina scored a 1 out of 5 for controversy – the highest score possible, reflecting that Illumina has managed to keep its nose clean.
Illumina share dividends
We're not expecting Illumina to pay a dividend over the next 12 months.
Have Illumina's shares ever split?
Illumina's shares were split on a 2:1 basis on 23 September 2008. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Illumina shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Illumina shares which in turn could have impacted Illumina's share price.
Illumina share price volatility
Over the last 12 months, Illumina's shares have ranged in value from as little as $208.35 up to $526. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Illumina's is 0.9309. This would suggest that Illumina's shares are less volatile than average (for this exchange).
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements, as well as cancer detection testing services. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. The company was incorporated in 1998 and is based in San Diego, California.
Stocks similar to Illumina
Illumina in the news
Illumina and Allegheny Health Network to Assess In-House Comprehensive Cancer Genomic Profiling to Enhance Patient Care
Illumina Named Top 100 Best Corporate Citizens and Ranked #1 in the Employee Category
Illumina's (ILMN) GRAIL, Intermountain Healthcare Expand Tie-Up
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More on investing
iGaming is now legal in Ontario. Find out which companies to keep an eye on with our list of 10 top online gaming stocks.Read more…
Enjoy perks like free trades and cash rewards when you open a stock trading account with these online brokers.Read more…
Here’s what you need to know about investing in the propane industry, including 3 popular propane stocks to watch.Read more…
More guides on Finder
How to buy Entain stock in Canada
Steps to owning and managing ENT stock, with 24-hour and historical pricing before you buy.
How to buy Kambi Group stock in Canada
Steps to owning and managing KAMBI stock, with 24-hour and historical pricing before you buy.
Best brokerage signup bonuses in 2022
Enjoy perks like free trades and cash rewards when you open a stock trading account with these online brokers.
How to buy Rush Street Interactive stock in Canada
Steps to owning and managing RSI stock, with 24-hour and historical pricing before you buy.
How to buy PointsBet stock in Canada
Steps to owning and managing PBTHF stock, with 24-hour and historical pricing before you buy.
How to buy Hanover Bancorp, Inc. (HNVR) stock in Canada when it goes public
Everything we know about the Hanover Bancorp, Inc. IPO, plus information on how to buy in.
How to buy PrimeBlock stock in Canada when it goes public
Everything we know about the PrimeBlock IPO, plus information on how to buy in.
How to buy Actelis Networks (ASNS) stock in Canada when it goes public
Everything we know about the Actelis Networks IPO, plus information on how to buy in.
How to buy ProFrac Holding Corp (PFHC) stock in Canada when it goes public
Everything we know about the ProFrac Holding Corp IPO, plus information on how to buy in.
How to buy Wytec International (WYTC) stock in Canada when it goes public
Everything we know about the Wytec International IPO, plus information on how to buy in.